QURE

Biotechnology QURE Uncategorized

uniQure upgraded at Mizuho on improved outlook for Huntington’s asset AMT-130

Mar 12, 2026

Biotechnology QURE Uncategorized

uniQure used ‘distorted comparison’ in Huntington’s asset trial: FDA official

Mar 6, 2026

Biotechnology QURE Richard Durant Uncategorized

uniQure: Worst Case Scenario Becomes Reality

Mar 4, 2026

Biotechnology QURE Uncategorized

uniQure plummets as FDA calls for phase 3 trial for Huntington’s asset AMT-130

Mar 2, 2026

Biotechnology Edmund Ingham QURE Uncategorized

uniQure: Shares Tumble On Fresh FDA Controversy – What Investors Should Know

Feb 27, 2026

Biotechnology QURE RGNX Uncategorized

uniQure falls after FDA commissioner’s comments on rare disease therapy

Feb 26, 2026

uniqure-gains-as-fda-sets-up-meeting-on-gene-therapy

Biotechnology QURE Uncategorized

uniQure gains as FDA sets up meeting on gene therapy

Jan 9, 2026

On the Move Comments Grandbrothers/iStock Editorial via Getty Images uniQure (QURE) added ~14% in the...